GMED certifies its first class D in vitro diagnostic medical devices under Regulation (EU) 2017/746

GMED informs you that its teams have just certified under Regulation (EU) 2017/746 the first four Class D in vitro diagnostic medical devices, the highest risk class.

Less than 8 months after the delivery of the first certificates under Regulation (EU) 2017/746, issuing these new certificates is a concrete expression of the commitments and investments made by GMED to support and serve its customers and future customers in their certification projects.

GMED thus confirms its ambitions to serve the healthcare industry on a large scale and to support innovation while enhancing patient safety.